Open AccessNew‐Onset Diabetes in Treated Hypertensive Patients‐Is It Clinically Significant?
Author(s) -
Moser Marvin,
Sowers James R.,
Oparil Suzanne,
Black Henry
Publication year - 2005
Publication title -
the journal of clinical hypertension
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.909
H-Index - 67
eISSN - 1751-7176
pISSN - 1524-6175
DOI - 10.1111/j.1524-6175.2005.04248.x
Subject(s) - medicine , diabetes mellitus , haven , gerontology , population , family medicine , endocrinology , mathematics , environmental health , combinatorics
Following a symposium on hypertension in Chicago on September 22, 2004, a roundtable discussion was held to discuss one of the emerging controversies in hypertension management, specifically the occurrence of new‐onset diabetes in treated nondiabetic hypertensive patients. How frequent is it? Is it just part of the metabolic syndrome that is common in hypertension, or do certain medications predispose patients to hyperglycemia? The question of the effect of other specific medications on insulin sensitivity and the possible reduction in the occurrence of diabetes in the hypertensive population with these agents was also discussed. Dr. Marvin Moser of the Yale University School of Medicine, New Haven, CT, moderated the discussion with Dr. James Sowers of the Missouri College of Medicine, Columbia, MO, Dr. Suzanne Oparil of the University of Alabama at Birmingham, Birmingham, AL, and Dr. Henry Black of the Rush College of Medicine, Chicago, IL.